JP2008545616A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008545616A5 JP2008545616A5 JP2007555704A JP2007555704A JP2008545616A5 JP 2008545616 A5 JP2008545616 A5 JP 2008545616A5 JP 2007555704 A JP2007555704 A JP 2007555704A JP 2007555704 A JP2007555704 A JP 2007555704A JP 2008545616 A5 JP2008545616 A5 JP 2008545616A5
- Authority
- JP
- Japan
- Prior art keywords
- dopa
- dopamine agonist
- medicament
- treatment
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0503540A GB0503540D0 (en) | 2005-02-21 | 2005-02-21 | Inhibition or treatment of dyskinesia |
| GB0508843A GB0508843D0 (en) | 2005-04-29 | 2005-04-29 | Inhibition or treatment of dyskinesia |
| PCT/GB2006/000583 WO2006087577A2 (en) | 2005-02-21 | 2006-02-20 | Inhibition or treatment of dyskinesia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008545616A JP2008545616A (ja) | 2008-12-18 |
| JP2008545616A5 true JP2008545616A5 (https=) | 2009-04-09 |
Family
ID=36691702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007555704A Withdrawn JP2008545616A (ja) | 2005-02-21 | 2006-02-20 | ジスキネジーの阻害または治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20080070952A1 (https=) |
| EP (1) | EP1850838A2 (https=) |
| JP (1) | JP2008545616A (https=) |
| CA (1) | CA2598484A1 (https=) |
| SG (1) | SG160342A1 (https=) |
| WO (1) | WO2006087577A2 (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT891332E (pt) * | 1996-03-29 | 2004-07-30 | Pfizer | Derivados de 6-fenilpiridil-2-amina |
| HN1997000027A (es) * | 1996-12-06 | 1997-06-05 | Pfizer Prod Inc | Derivados de 6-fenil piridil - 2 amina |
| JP3505189B2 (ja) * | 1997-02-10 | 2004-03-08 | ファイザー・プロダクツ・インク | ２−アミノ−６−（２−置換−４−フェノキシ）−置換ピリジン |
| WO1998048826A1 (en) * | 1997-04-30 | 1998-11-05 | Northwestern University | Inhibition of nitric oxide synthase by amino acids and dipeptides |
| US6803486B2 (en) * | 2001-06-22 | 2004-10-12 | Northwestern University | Selective neuronal nitric oxide synthase inhibitors |
| US20030232739A1 (en) * | 2001-08-15 | 2003-12-18 | Pfizer Inc. | Pharmaceutical combinations comprising a NOS inhibitor and an NMDA receptor antagonist |
| DOP2002000467A (es) * | 2001-10-10 | 2003-04-15 | Pfizer Prod Inc | 2-amino-6 (fenilo sustituido en las posiciones 2,4,5)-piridinas |
| US6803470B2 (en) * | 2001-10-10 | 2004-10-12 | Pfizer Inc | 2-amino-6-(2,4,5-substituted-phenyl)-pyridines |
| CA2538339A1 (en) * | 2003-09-08 | 2005-03-24 | Northwestern University | Heteroaromatic selective inhibitors of neuronal nitric oxide synthase |
-
2006
- 2006-02-20 CA CA002598484A patent/CA2598484A1/en not_active Abandoned
- 2006-02-20 SG SG201001316-7A patent/SG160342A1/en unknown
- 2006-02-20 JP JP2007555704A patent/JP2008545616A/ja not_active Withdrawn
- 2006-02-20 WO PCT/GB2006/000583 patent/WO2006087577A2/en not_active Ceased
- 2006-02-20 US US11/884,240 patent/US20080070952A1/en not_active Abandoned
- 2006-02-20 EP EP06709819A patent/EP1850838A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2444072A3 (en) | Non-mucoadhesive film dosage forms | |
| JP2013505282A5 (https=) | ||
| FI3782612T3 (fi) | Sytidiinianalogien oraalisia formulaatioita ja menetelmiä niiden käyttämiseksi | |
| CA2683786C (en) | Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects | |
| WO2007012022A3 (en) | Unit dose form with ibuprofen-famotidine admixture | |
| WO2008011426A3 (en) | Methods and medicaments for administration of ibuprofen | |
| MX2009002196A (es) | Oblea de buprenorfina para terapia de sustitucion de farmacos. | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| WO2008064192A3 (en) | Modified release analgesic suspensions | |
| JP2008044951A5 (https=) | ||
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| UA105644C2 (uk) | Способи лікування легеневих порушень складами ліпосомального амікацину | |
| NZ613291A (en) | Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof | |
| JP2013541583A5 (https=) | ||
| ATE505203T1 (de) | Pharmazeutische kombination aus aliskiren und valsartan | |
| CL2007002574A1 (es) | Composicion farmaceutica oral que comprende levodopa en una dosis unitaria de alrededor de 100 hasta alrededor de 500 mg y un excipiente adecuado; y su uso para tratar parkinson. | |
| JP2013536837A5 (https=) | ||
| WO2008070010A3 (en) | Hydroxylamine derivatives for the treatment of stroke | |
| MX2013005482A (es) | Composicion farmaceutica que contiene sales de citrato y bicarbonato, y su uso para el tratamiento de la cistinuria. | |
| WO2007145863A3 (en) | Sustained release formulation of naltrexone | |
| TNSN08506A1 (en) | Substituted carboxamides | |
| JP2011500589A5 (https=) | ||
| RU2008134143A (ru) | Фармацевтическая композиция цитиколина, холина альфосцерата и l-карнитина (или ацетил-l-карнитина) для лечения и профилактики заболеваний центральной нервной системы и способ лечения | |
| NZ591328A (en) | Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof | |
| UA90893C2 (ru) | Пероральная дозированная форма производных гемцитабина |